Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?

Affiliations

• ¹ Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10000, Zagreb, Croatia. p.petranovic@gmail.com.
• ² School of Medicine, University of Zagreb, 10000, Zagreb, Croatia. p.petranovic@gmail.com.
• ³ Department of Nuclear Medicine and Radiology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands.
• ⁴ Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, 98100, Messina, Italy.
• ⁵ Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Otto-Von-Guericke University, 39120, Magdeburg, Germany.
• ⁶ Institute Gustave Roussy, 94800, Villejuif, France.
• ⁷ Department of Nuclear Medicine, Hacettepe University, 06230, Ankara, Turkey.
• ⁸ Department of Nuclear Medicine, Gruppo Ospedaliero Moncucco SA, Clinica Moncucco, Via Soldino 10, 6900, Lugano, Switzerland.
• ⁹ Clinic for Nuclear Medicine, University Hospital of Zürich, 8004, Zurich, Switzerland.